We are a research-based specialty
biopharma company determined
to give people all over the world a
longer and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more

R&D

Scandinavian Biopharma

The first children have been vaccinated in Scandinavian Biopharma's large Phase IIb study in The Gambia

Scandinavian Biopharma announces that the first child has been vaccinated in The Gambia with the company's ETEC vaccine candidate, ETVAX®. It is a randomised, placebo-controlled, and double-blind phase IIb study. The study will include about 5,[...]
Read more

Scandinavian Biopharma

We welcome Tomas Danielsson as Senior Project Manager Manufacturing at Scandinavian Biopharma

Despite the corona pandemic, with all its challenges, we continue to grow and once more start the year by welcoming new colleagues. We are now further strengthening our organisation within manufacturing and are pleased to welcome Tomas Danielsso[...]
Read more